California-based medical device company Atia Vision, Inc. has completed the second tranche of its Series C financing round, securing $10 million.
Atia Vision plans to use the funds to move its novel technology into clinical trials and reveal its impact on patients suffering from visual impairment.
The Capital Partnership led the Series C round with participation from Medvance Incubator Partners and Cormorant Healthcare Fund.
Atia Vision has raised a total of $15 million in over 3 funding rounds.